Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Thomas Jensen

Concepts (137)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Glucagon-Like Peptides
6
2024
76
0.950
Why?
Glucagon-Like Peptide 1
1
2025
150
0.800
Why?
Fatty Liver
1
2025
252
0.730
Why?
Stroke Volume
5
2024
652
0.570
Why?
Obesity
8
2024
3131
0.430
Why?
Liraglutide
3
2020
32
0.410
Why?
Atrial Premature Complexes
2
2004
3
0.410
Why?
Heart Failure
5
2024
2329
0.400
Why?
Atrial Fibrillation
3
2024
560
0.390
Why?
Diabetes Mellitus, Type 2
6
2024
2623
0.310
Why?
Metabolic Syndrome
2
2025
364
0.290
Why?
Natriuretic Peptide, Brain
2
2024
110
0.240
Why?
Double-Blind Method
9
2024
2070
0.230
Why?
Incretins
1
2025
21
0.220
Why?
Bridged Bicyclo Compounds, Heterocyclic
3
2013
292
0.200
Why?
Tachycardia, Paroxysmal
1
2003
8
0.200
Why?
Diabetic Angiopathies
3
2020
265
0.190
Why?
Liver Cirrhosis
1
2025
278
0.190
Why?
Body Composition
3
2013
689
0.180
Why?
Non-alcoholic Fatty Liver Disease
1
2025
265
0.180
Why?
Cardiovascular Diseases
3
2023
2219
0.170
Why?
Receptors, Vasopressin
1
2021
20
0.160
Why?
Vasopressins
1
2021
60
0.160
Why?
Peptide Fragments
1
2024
693
0.150
Why?
Fructose
1
2021
132
0.150
Why?
Quality of Life
3
2023
3200
0.150
Why?
Cardiovascular System
1
2020
137
0.140
Why?
Hypoglycemic Agents
4
2023
1412
0.120
Why?
Weight Loss
3
2013
858
0.120
Why?
Metformin
1
2020
328
0.120
Why?
Aldehyde Reductase
1
1996
31
0.120
Why?
Angiotensin-Converting Enzyme Inhibitors
1
1996
228
0.110
Why?
Aged
12
2024
26432
0.100
Why?
Naltrexone
1
2015
114
0.100
Why?
Electrocardiography, Ambulatory
2
2004
64
0.100
Why?
Humans
25
2025
146342
0.090
Why?
Treatment Outcome
7
2024
11821
0.090
Why?
Narcotic Antagonists
1
2015
210
0.090
Why?
Anti-Obesity Agents
2
2009
67
0.090
Why?
Middle Aged
12
2024
36619
0.080
Why?
Diabetes Mellitus, Type 1
3
2016
3930
0.080
Why?
Male
16
2024
73396
0.080
Why?
Factor VIII
1
2010
107
0.070
Why?
Alcoholism
1
2015
830
0.070
Why?
Female
14
2024
79499
0.060
Why?
Hyperlipidemias
2
2000
120
0.060
Why?
Drug Therapy, Combination
2
2020
1036
0.060
Why?
Bundle-Branch Block
1
2005
37
0.060
Why?
Ventricular Fibrillation
1
2005
63
0.050
Why?
Systole
1
2005
179
0.050
Why?
Prevalence
2
2020
2861
0.050
Why?
Anticoagulants
1
2010
746
0.050
Why?
Sodium Potassium Chloride Symporter Inhibitors
1
2024
17
0.050
Why?
Diuretics
1
2024
66
0.050
Why?
Adult
10
2020
41087
0.050
Why?
Tachycardia, Ventricular
1
2005
179
0.050
Why?
Catheter Ablation
2
2005
355
0.050
Why?
Antibodies, Monoclonal
1
2010
1512
0.050
Why?
Statistics, Nonparametric
1
2003
426
0.050
Why?
Neoplasms
1
2018
2954
0.050
Why?
Cytochrome c Group
1
2002
43
0.040
Why?
Pseudomonas
1
2002
30
0.040
Why?
Randomized Controlled Trials as Topic
2
2020
1763
0.040
Why?
Hep G2 Cells
1
2021
74
0.040
Why?
Drinking
1
2021
44
0.040
Why?
Fructokinases
1
2021
42
0.040
Why?
Arteriosclerosis
2
1997
82
0.040
Why?
Placebos
1
2018
192
0.030
Why?
Injections, Subcutaneous
1
2016
170
0.030
Why?
Albuminuria
1
1997
190
0.030
Why?
Denmark
3
2008
51
0.030
Why?
Case-Control Studies
1
2003
3647
0.030
Why?
Diabetic Neuropathies
1
1996
101
0.030
Why?
Prospective Studies
2
2005
8123
0.030
Why?
Clinical Trials, Phase III as Topic
1
2015
116
0.030
Why?
Aged, 80 and over
2
2018
8391
0.030
Why?
Young Adult
4
2016
14330
0.030
Why?
Prognosis
2
2020
4351
0.030
Why?
Mice, Knockout
1
2021
3125
0.020
Why?
Hyperlipidemia, Familial Combined
1
1993
2
0.020
Why?
Adolescent
5
2016
22557
0.020
Why?
Liver
1
2021
1864
0.020
Why?
Inflammation
1
2023
2919
0.020
Why?
Follow-Up Studies
2
2018
5439
0.020
Why?
Chemistry, Clinical
1
1990
5
0.020
Why?
Metabolic Clearance Rate
1
2010
115
0.020
Why?
Sweat Glands
1
1990
5
0.020
Why?
Cell Transformation, Viral
1
1990
23
0.020
Why?
Half-Life
1
2010
157
0.020
Why?
Disease Models, Animal
1
2021
4580
0.020
Why?
Hospitalization
1
2020
2475
0.020
Why?
Mice, Inbred C57BL
1
2021
6034
0.020
Why?
Area Under Curve
1
2010
335
0.020
Why?
Nasal Polyps
1
1990
59
0.020
Why?
Risk Factors
3
2018
10921
0.020
Why?
Lipoproteins
1
1990
165
0.020
Why?
Alcohol Drinking
1
2015
850
0.020
Why?
Caloric Restriction
1
2008
133
0.020
Why?
Dose-Response Relationship, Drug
1
2010
2022
0.010
Why?
Insulin
1
2016
2525
0.010
Why?
Lipids
1
1990
714
0.010
Why?
Hemorrhage
1
2010
825
0.010
Why?
Syndrome
1
2005
380
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2010
992
0.010
Why?
Logistic Models
1
2008
2126
0.010
Why?
Mice
1
2021
18297
0.010
Why?
Radiography
1
2005
861
0.010
Why?
Guanidine
1
2002
21
0.010
Why?
Calorimetry, Differential Scanning
1
2002
35
0.010
Why?
Spectrophotometry
1
2002
58
0.010
Why?
Protein Denaturation
1
2002
76
0.010
Why?
Electrocardiography
1
2005
667
0.010
Why?
Retrospective Studies
1
2020
17438
0.010
Why?
Circular Dichroism
1
2002
149
0.010
Why?
Controlled Clinical Trials as Topic
1
2000
26
0.010
Why?
Protein Folding
1
2002
281
0.010
Why?
Hypolipidemic Agents
1
2000
89
0.010
Why?
Cystic Fibrosis
1
1990
1164
0.010
Why?
Protein Structure, Tertiary
1
2002
834
0.010
Why?
Kinetics
1
2002
1553
0.010
Why?
Time Factors
1
2009
7109
0.010
Why?
Animals
1
2021
38107
0.010
Why?
Models, Molecular
1
2002
1574
0.010
Why?
Practice Guidelines as Topic
1
2000
1591
0.010
Why?
Cell Line, Transformed
1
1990
137
0.000
Why?
Keratins
1
1990
57
0.000
Why?
Microscopy, Electron
1
1990
384
0.000
Why?
Reference Values
1
1990
796
0.000
Why?
Cell Division
1
1990
736
0.000
Why?
Cell Survival
1
1990
1105
0.000
Why?
Cohort Studies
1
1997
6077
0.000
Why?
Epithelial Cells
1
1990
1119
0.000
Why?
DNA
1
1990
1421
0.000
Why?
Infant, Newborn
1
1993
6460
0.000
Why?
Infant
1
1993
10114
0.000
Why?
Child, Preschool
1
1993
11913
0.000
Why?
Child
1
1993
22693
0.000
Why?
Jensen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)